DexaSite dexamethasone: Phase III delayed

InSite said in its 2Q12 earnings that it will delay until further notice the start of a Phase III trial to evaluate DexaSite to save cash and focus on ongoing Phase III DOUBle trial to treat blepharitis and clinical trials of BromSite. Details were not disclosed. The company is evaluating its AzaSite Plus ( ISV-502) in DOUBle trial, while BromSite is in Phase III testing to treat ocular inflammation and pain in patients undergoing cataract surgery. ...